欢迎来到CSNpharm！产品仅用于科研！

400-920-2911 sales@csnpharm.cn

NEW 新产品
0

Angiotensin Receptor

Angiotensin Receptor

货号 产品名 CAS号 信息
CSN25363 ZD 7155(hydrochloride) 146709-78-6 ZD 7155 hydrochloride is selective competitive antagonist of the angiotensin II type 1 (AT1) receptor.
CSN12536 Valsartan 137862-53-4 Valsartan is a selective angiotensin II AT1 receptor antagonist with elimination half-life‎ of ‎6 hours.
CSN16012 trans-Tranilast 70806-55-2 trans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
CSN17430 Tranilast sodium 104931-56-8 Tranilast is an antiallergic agent.
CSN12122 Tranilast 53902-12-8 Tranilast can antagonize angiotensin II and also work as an antiallergic agent. It showed inhibitory effect for NLRP3 inflammasome but not for NLRC4 or AIM2 inflammasome. Tranilast impaired the endogenous NLRP3-ASC interaction but did not affect the NLRP3-NEK7 interaction, raising the possibility that it targets NLRP3 directly.
CSN12552 Telmisartan 144701-48-4 Telmisartan is an angiotensin II receptor antagonist with Ki value of 3.7nM, used in the management of hypertension with elimination half-life‎ of ‎24 hours.
CSN12037 Tasosartan 145733-36-4 Tasosartan is a long-acting angiotensin II receptor blocker.
CSN21304 SL910102 144756-71-8 SL910102 is a nonpeptide angiotensin AT1 receptor antagonist.
CSN16875 PD 123319 ditrifluoroacetate 136676-91-0 PD123319 Ditrifluoroacetate is a potent, selective and non-peptide angiotensin AT2 receptor antagonist.
CSN11662 PD 123319 130663-39-7 PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.
CSN12551 Olmesartan medoxomil 144689-63-4 Olmesartan Medoxomil is a synthetic imidazole-derived angiotensin II receptor antagonist, acting as a prodrug with an antihypertensive property.
CSN11603 Olmesartan 144689-24-7 Olmesartan is an antagonist of angiotensin II receptor, working as an antihypertensive agent.
CSN12515 Losartan potassium 124750-99-8 Losartan Potassium is the potassium salt form of Losartan, which is a compeitive AT1 receptor inhibitor with IC50 value of 20 nM.
CSN11333 Losartan 114798-26-4 Losartan is a compeitive AT1 receptor inhibitor with IC50 value of 20 nM.
CSN17407 Losartan D4 1030937-27-9 Losartan D4 is deuterium labeled Losartan, which is an angiotensin II receptor antagonist.
CSN16211 Sacubitril/Valsartan 936623-90-4 LCZ 696 is a mixture of neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan in a ratio of 1:1.
CSN22035 L-159282 157263-00-8 L-159282 is a highly potent, orally active, nonpeptide angiotensin II receptor antagonist, with anti-hypertensive activity.
CSN12537 Irbesartan 138402-11-6 Irbesartan is a selective and competitive nonpeptide angiotensin II antagonist with antihypertensive activity.
CSN13567 Fimasartan 247257-48-3 Fimasartan is an improved non-peptide angiotensin II receptor blocker used for the treatment of hypertension and heart failure, which enables higher potency and longer duration than losartan.
CSN24625 Losartan Carboxylic Acid 124750-92-1 EXP 3174 is a selective and noncompetitive antagonist of AT1 receptor with IC50 of 37 nM.
CSN10923 Eprosartan mesylate 144143-96-4 Eprosartan Mesylate is a reversible and competitive angiotensin II receptor inhibitor.
CSN10922 Eprosartan 133040-01-4 Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure.
CSN18823 Olodanrigan 1316755-16-4 EMA401, a highly selective AT2R antagonist, inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons.
CSN17650 CGP-42112 127060-75-7 CGP-42112 is a potent Angiotensin-II subtype 2 receptor (AT2 R) agonist.
CSN12544 Candesartan 139481-59-7 Candesartan is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 0.26 nM.
CSN12553 Candesartan Cilexetil 145040-37-5 Candesartan Cilexetil is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 0.26 nM.
CSN17695 BIBS 39 133085-33-3 BIBS 39 is a nonpeptide angiotensin II (AII) receptor antagonist.
CSN12705 Azilsartan medoxomil 863031-21-4 Azilsartan Medoxomil is an orally available angiotensin II type 1 (AT1) receptor antagonist with IC50 value of 2.6 nM.
CSN13633 Azilsartan medoxomil monopotassium 863031-24-7 Azilsartan medoxomil is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension.
CSN10369 Azilsartan   147403-03-0 Azilsartan is an orally available angiotensin II type 1 (AT1) receptor antagonist with IC50 value of 2.6 nM.
CSN16922 AVE 0991 sodium salt 306288-04-0 AVE 0991 sodium is a nonpeptide Ang-(1-7) receptor Mas agonist, represents an important step for exploration of the effects of Ang-(1-7) and testing of its potential as a cardiovascular drug.
CSN16917 AVE 0991 304462-19-9 AVE 0991 is a nonpeptide Ang-(1-7) receptor Mas agonist.
CSN20314 AT2 receptor agonist C21 477775-14-7 AT2R agonist C21 is a small-molecule ATR receptor (AT2R) agonist.
CSN10313 Angiotensin II human 4474-91-3 Angiotensin II human is a peptide hormone that causes vasoconstriction and a subsequent increase in blood pressure.
CSN10119 Angiotensin II 5-valine 58-49-1 Angiotensin II 5-valine is an angiotensin II analog which is an agonist at angiotensin receptors.
CSN21490 Angiotensin II (3-8), human 12676-15-2 Angiotensin II (3-8), human is an agonist of angiotensin AT1 receptor. Its activation is relatively weak.
CSN13483 Sacubitril 149709-62-6 AHU-377 and valsartan can compose LCZ696 in a 1:1 molar ratio. It also works as an inhibitor of neprilysin with IC50 value of 5 nM.
CSN22012 A81988 141887-34-5 A81988 is a potent, competitive, non-peptidic antagonist of angiotensin AT1 receptors.
CSN21995 (2S,4S)-Sacubitril 149709-63-7 2S,4S-Sacubitril is the impurity of Sacubitril and Sacubitril is approved by the Food and Drug Administration for use in combination with valsartan for the treatment of patients with heart failure.
CSN21996 2R,4S-Sacubitril 761373-05-1 2R,4S-Sacubitril is the impurity of Sacubitril and Sacubitril is approved by the Food and Drug Administration for use in combination with valsartan for the treatment of patients with heart failure.
CSN28996 Sparsentan 254740-64-2
<< PREV 1 2 NEXT >>
dandb BBB norton fedex dhl ups 顺丰
联系
我们